» Articles » PMID: 7014468

Opsonization of Encapsulated Cryptococcus Neoformans by Specific Anticapsular Antibody

Overview
Journal Infect Immun
Date 1981 Mar 1
PMID 7014468
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Antisera prepared in rabbits against either whole encapsulated cells of Cryptococcus neoformans or purified cryptococcal polysaccharide were opsonic for the encapsulated yeast. The opsonic activity was removed by absorption with whole cryptococci and was inhibited by free polysaccharide. As little as 0.13 microgram of cryptococcal polysaccharide produced a 50% inhibition of opsonization. Various degrees of neutralization by polysaccharides from the four cryptococcal serotypes suggested that the opsonins were type specific. Fractionation of antiserum on Bio-Gel A-5m (Bio-Rad Laboratories) and diethylaminoethyl cellulose showed that the opsonins were antibodies of the immunoglobulin G class. These opsonizing antibodies did not require heat-labile serum components for optimal phagocytosis of the yeast. Inhibition studies using 2-deoxy-D-glucose demonstrated that ingestion of encapsulated cryptococci opsonized with anticapsular antibody was a 2-deoxy-D-glucose-inhibitable process. This result differed from similar studies with non-encapsulated cryptococci which showed that ingestion of non-encapsulated cryptococci opsonized with normal serum was not inhibited by 2-deoxy-D-glucose.

Citing Articles

Adaptive Immunity to Infections.

Mukaremera L, Nielsen K J Fungi (Basel). 2018; 3(4).

PMID: 29333430 PMC: 5753166. DOI: 10.3390/jof3040064.


Cryptococcus neoformans: historical curiosity to modern pathogen.

Srikanta D, Santiago-Tirado F, Doering T Yeast. 2013; 31(2):47-60.

PMID: 24375706 PMC: 3938112. DOI: 10.1002/yea.2997.


A sensitive high-throughput assay for evaluating host-pathogen interactions in Cryptococcus neoformans infection.

Srikanta D, Yang M, Williams M, Doering T PLoS One. 2011; 6(7):e22773.

PMID: 21829509 PMC: 3145667. DOI: 10.1371/journal.pone.0022773.


Cryptococcal interactions with the host immune system.

Voelz K, May R Eukaryot Cell. 2010; 9(6):835-46.

PMID: 20382758 PMC: 2901644. DOI: 10.1128/EC.00039-10.


Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans.

Kelly R, Chen J, Yauch L, Levitz S Infect Immun. 2004; 73(1):592-8.

PMID: 15618199 PMC: 539000. DOI: 10.1128/IAI.73.1.592-598.2005.


References
1.
Shahar A, Aronson M . Formation of histiocyte rings in response to Cryptococcus neoformans infection. J Reticuloendothel Soc. 1965; 2(3):249-55. View

2.
DIAMOND R . Effects of stimulation and suppression of cell-mediated immunity on experimental cryptococcosis. Infect Immun. 1977; 17(1):187-94. PMC: 421100. DOI: 10.1128/iai.17.1.187-194.1977. View

3.
Kozel T, Cazin J . Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide. Infect Immun. 1971; 3(2):287-94. PMC: 416145. DOI: 10.1128/iai.3.2.287-294.1971. View

4.
Bennett J, Hasenclever H . CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE: STUDIES OF SEROLOGIC PROPERTIES AND ROLE IN INFECTION. J Immunol. 1965; 94:916-20. View

5.
Kozel T, McGaw T . Opsonization of Cryptococcus neoformans by human immunoglobulin G: role of immunoglobulin G in phagocytosis by macrophages. Infect Immun. 1979; 25(1):255-61. PMC: 414445. DOI: 10.1128/iai.25.1.255-261.1979. View